Journal
CELL
Volume 128, Issue 1, Pages 197-209Publisher
CELL PRESS
DOI: 10.1016/j.cell.2006.11.044
Keywords
-
Categories
Funding
- Medical Research Council [MC_U137961144, MC_U137961145] Funding Source: Medline
- MRC [MC_U137961145, MC_U137961144] Funding Source: UKRI
- Medical Research Council [G0300058B, MC_U137961144, MC_U137961145] Funding Source: researchfish
Ask authors/readers for more resources
We have devised a strategy (called recombinase-mediated genomic replacement, RMGR) to allow the replacement of large segments (> 100 kb) of the mouse genome with the equivalent human syntenic region. The technique involves modifying a mouse ES cell chromosome and a human BAC by inserting heterotypic lox sites to flank the proposed exchange interval and then using Cre recombinase to achieve segmental exchange. We have demonstrated the feasibility of this approach by replacing the mouse alpha globin regulatory domain with the human syntenic region and generating homozygous mice that produce only human a globin chains. Furthermore, modified ES cells can be used iteratively for functional studies, and here, as an example, we have used RMGR to produce an accurate mouse model of human alpha thalassemia. RMGR has general applicability and will overcome limitations inherent in current transgenic technology when studying the expression of human genes and modeling human genetic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available